{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:18:37Z","timestamp":1784200717441,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Western Pacific Region (WPR) is exposed each year to seasonal influenza and is often the source of new influenza virus variants and novel pathogen emergence. National influenza surveillance systems play a critical role in detecting emerging viruses, monitoring influenza epidemics, improving public disease awareness and promoting pandemic preparedness, but vary widely across WPR countries. The aim of this study is to improve existing influenza surveillance systems by systematically comparing selected WPR influenza surveillance systems.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Three national influenza surveillance systems with different levels of development (Australia, China and Malaysia) were compared and their adherence to World Health Organization (WHO) guidance was evaluated using a structured framework previously tested in several European countries consisting of seven surveillance sub-systems, 19 comparable outcomes and five evaluation criteria. Based on the results, experts from the Asia-Pacific Alliance for the Control of Influenza (APACI) issued recommendations for the improvement of existing surveillance systems.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Australia demonstrated the broadest scope of influenza surveillance followed by China and Malaysia. In Australia, surveillance tools covered all sub-systems. In China, surveillance did not cover non-medically attended respiratory events, primary care consultations, and excess mortality modelling. In Malaysia, surveillance consisted of primary care and hospital sentinel schemes. There were disparities between the countries across the 5 evaluation criteria, particularly regarding data granularity from health authorities, information on data representativeness, and data communication, especially the absence of publicly available influenza epidemiological reports in Malaysia. This dual approach describing the scope of surveillance and evaluating the adherence to WHO guidance enabled APACI experts to make a number of recommendations for each country that included but were not limited to introducing new surveillance tools, broadening the use of specific existing surveillance tools, collecting and sharing data on virus characteristics, developing immunization status registries, and improving public health communication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Influenza monitoring in Australia, China, and Malaysia could benefit from the expansion of existing surveillance sentinel schemes, the broadened use of laboratory confirmation and the introduction of excess-mortality modelling. The results from the evaluation can be used as a basis to support expert recommendations and to enhance influenza surveillance capabilities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11765-x","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:02:25Z","timestamp":1632614545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of influenza surveillance systems in Australia, China, Malaysia and expert recommendations for influenza control"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0196-4357","authenticated-orcid":false,"given":"Clotilde","family":"El Guerche-S\u00e9blain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Rigoine De Fougerolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Van Buynder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zamberi","family":"Sekawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Yee-Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Vitoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kevin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Schellevis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vanhems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"issue":"SUPPL.3","key":"11765_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/irv.12180","volume":"7","author":"LC Jennings","year":"2013","unstructured":"Jennings LC. Influenza vaccines: An Asia-Pacific perspective. Influenza Other Respir Viruses. 2013;7(SUPPL.3):44\u201351. https:\/\/doi.org\/10.1111\/irv.12180.","journal-title":"Influenza Other Respir Viruses"},{"issue":"8984","key":"11765_CR2","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S0140-6736(95)92906-1","volume":"346","author":"KF Shortridge","year":"1995","unstructured":"Shortridge KF. The next pandemic influenza virus? Lancet. 1995;346(8984):1210\u20132. https:\/\/doi.org\/10.1016\/S0140-6736(95)92906-1.","journal-title":"Lancet."},{"issue":"3","key":"11765_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/ije\/dyaa033","volume":"49","author":"NC Peeri","year":"2020","unstructured":"Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;49(3):717\u201326. https:\/\/doi.org\/10.1093\/ije\/dyaa033.","journal-title":"Int J Epidemiol"},{"key":"11765_CR4","unstructured":"WHO. Why measure Influenza Burden of Disease (BoD). :4. http:\/\/www.who.int\/influenza\/surveillance_monitoring\/bod\/MeasuringBOD_Infographic.pdf?ua=1."},{"key":"11765_CR5","unstructured":"WHO. Fifth meeting of national influenza centres in the Western Pacific and South-East Asia regions. WHO Website. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/241881\/WER8707_61-64.PDF?sequence=1&isAllowed=y. Accessed 23 Sept 2021."},{"issue":"6","key":"11765_CR6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.vaccine.2016.12.064","volume":"35","author":"BJ Cowling","year":"2017","unstructured":"Cowling BJ, Caini S, Chotpitayasunondh T, Djauzi S, Gatchalian SR, Huang QS, et al. Influenza in the Asia-Pacific region: findings and recommendations from the global influenza initiative. Vaccine. 2017;35(6):856\u201364. https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.064.","journal-title":"Vaccine."},{"issue":"10127","key":"11765_CR7","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285\u2013300. https:\/\/doi.org\/10.1016\/S0140-6736(17)33293-2.","journal-title":"Lancet."},{"key":"11765_CR8","first-page":"1","volume-title":"World Health Organization- Global Influenza Surveillance and Response System","author":"WHO","year":"2018","unstructured":"WHO. World Health Organization- Global Influenza Surveillance and Response System; 2018. p. 1\u20132. https:\/\/www.who.int\/influenza\/gisrs_laboratory\/updates\/GISRS_one_pager_2018_EN.pdf?ua=1"},{"key":"11765_CR9","unstructured":"WHO. FluNet Charts. https:\/\/www.who.int\/tools\/flunet. Accessed 23 Sept 2021."},{"key":"11765_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5365\/wpsar.2017.8.1.004","volume":"8","author":"Members of the WHO Western Pacific Region Global Influenza Surveillance and Response System","year":"2017","unstructured":"Members of the WHO Western Pacific Region Global Influenza Surveillance and Response System. Epidemiological and virological characteristics of seasonal influenza in the Western Pacific Region of the World Health Organization, 2011\u20132015. West Pacific Surveill response. J WPSAR. 2017;8:40\u20139.","journal-title":"J WPSAR"},{"key":"11765_CR11","volume-title":"Global Influenza Strategy 2019-2030","author":"WHO","year":"2019","unstructured":"WHO. Global Influenza Strategy 2019-2030. 2019. http:\/\/apps.who.int\/bookorders."},{"key":"11765_CR12","volume-title":"Influenza Vaccine Post-Introduction Evaluation (IPIE). WHO website","author":"WHO","year":"2018","unstructured":"WHO. Influenza Vaccine Post-Introduction Evaluation (IPIE). WHO website. 2018. https:\/\/www.who.int\/immunization\/research\/development\/ipie_influenza_post_introduction_evaluation\/en\/. Accessed 23 Dec 2020."},{"issue":"4","key":"11765_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/irv.12374","volume":"10","author":"S Hirve","year":"2016","unstructured":"Hirve S, Lambach P, Paget J, Vandemaele K, Fitzner J, Zhang W. Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review. Influenza Other Respir Viruses. 2016;10(4):254\u201367. https:\/\/doi.org\/10.1111\/irv.12374.","journal-title":"Influenza Other Respir Viruses"},{"issue":"45","key":"11765_CR14","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1016\/j.vaccine.2016.07.045","volume":"34","author":"JR Ortiz","year":"2016","unstructured":"Ortiz JR, Perut M, Dumolard L, Wijesinghe PR, Jorgensen P, Ropero AM, et al. A global review of national influenza immunization policies: analysis of the 2014 WHO\/UNICEF joint reporting form on immunization. Vaccine. 2016;34(45):5400\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.045.","journal-title":"Vaccine."},{"issue":"42","key":"11765_CR15","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1016\/j.vaccine.2015.08.082","volume":"33","author":"A Palache","year":"2015","unstructured":"Palache A, Oriol-Mathieu V, Fino M, Xydia-Charmanta M. Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): little progress in estimated global vaccination coverage. Vaccine. 2015;33(42):5598\u2013605. https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.082.","journal-title":"Vaccine."},{"issue":"35","key":"11765_CR16","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1016\/j.vaccine.2019.07.011","volume":"37","author":"A Sheldenkar","year":"2019","unstructured":"Sheldenkar A, Lim F, Yung CF, Lwin MO. Acceptance and uptake of influenza vaccines in Asia: a systematic review. Vaccine. 2019;37(35):4896\u2013905. https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.011.","journal-title":"Vaccine."},{"issue":"8","key":"11765_CR17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.vaccine.2015.11.065","volume":"34","author":"A Thomson","year":"2016","unstructured":"Thomson A, Robinson K, Vall\u00e9e-Tourangeau G. The 5As: a practical taxonomy for the determinants of vaccine uptake. Vaccine. 2016;34(8):1018\u201324. https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.065.","journal-title":"Vaccine."},{"issue":"11","key":"11765_CR18","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/21645515.2018.1489948","volume":"14","author":"PR Blank","year":"2018","unstructured":"Blank PR. Van Essen GA, Ortiz de Lejarazu R, Kyncl J, Nitsch-Osuch a, Kuchar EP, et al. impact of European vaccination policies on seasonal influenza vaccination coverage rates: an update seven years later. Hum Vaccin Immunother. 2018;14(11):2706\u201314. https:\/\/doi.org\/10.1080\/21645515.2018.1489948.","journal-title":"Hum Vaccin Immunother"},{"key":"11765_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2020-9-5","volume":"9","author":"G Kassianos","year":"2021","unstructured":"Kassianos G, Banerjee A, Baron-Papillon F, Hampson AW, McElhaney JE, McGeer A, et al. Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries. Drugs Context. 2021;9:1\u201313. https:\/\/doi.org\/10.7573\/dic.2020-9-5.","journal-title":"Drugs Context"},{"key":"11765_CR20","volume-title":"The 7th ESWI Influenza Conference","author":"T Rigoine de Fougerolles","year":"2020","unstructured":"Rigoine de Fougerolles T. National influenza surveillance systems in five European countries: a comparative framework based on WHO guidance. In: The 7th ESWI Influenza Conference; 2020."},{"key":"11765_CR21","unstructured":"WHO. A Manual for Estimating Disease Burden Associated with Seasonal Influenza. Who; 2015. p. 124. http:\/\/www.who.int\/influenza\/resources\/publications\/manual_burden_of_disease\/en\/."},{"key":"11765_CR22","volume-title":"Global Epidemiological Surveillance Standards for Influenza","author":"WHO","year":"2013","unstructured":"WHO. Global Epidemiological Surveillance Standards for Influenza. 2013. https:\/\/www.who.int\/publications\/i\/item\/9789241506601."},{"key":"11765_CR23","unstructured":"WHO. Influenza Transmission Zones. 2018. https:\/\/www.who.int\/influenza\/surveillance_monitoring\/updates\/Influenza_Transmission_Zones20180914.pdf. Accessed 23 Sept 2021."},{"key":"11765_CR24","unstructured":"WHO. WHO Western Pacific Region - Where we work. https:\/\/www.who.int\/westernpacific\/about\/where-we-work#:~:text=The%20Western%20Pacific%20Region%20is%20one%20of%20the,more%20than%20one%20quarter%20of%20the%20world%E2%80%99s%20population. Accessed 23 Sept 2021."},{"key":"11765_CR25","unstructured":"Australian Government Department of Health. National Immunisation Program. Department of Health website. 2020."},{"key":"11765_CR26","unstructured":"Ministry of Health Malaysia. Immunization Schedule. My health for life. 2020."},{"key":"11765_CR27","volume-title":"Technical guidance for influenza vaccination for the season 2020\/2021","author":"Chinese Center for Disease Control and Prevention","year":"2020","unstructured":"Chinese Center for Disease Control and Prevention. Technical guidance for influenza vaccination for the season 2020\/2021. 2020."},{"key":"11765_CR28","unstructured":"Australian Government Department of Health. Australian Influenza Surveillance Report and Activity Updates. https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-ozflu-flucurr.htm. Accessed 23 Sept 2021."},{"issue":"3","key":"11765_CR29","first-page":"E351","volume":"40","author":"SG Sullivan","year":"2016","unstructured":"Sullivan SG, Raupach J, Franklin LJ, Pennington K, Bareja C, de Kluyver R. A brief overview of influenza surveillance systems in Australia, 2015. Commun Dis Intell Q Rep. 2016;40(3):E351\u20135.","journal-title":"Commun Dis Intell Q Rep"},{"key":"11765_CR30","volume-title":"Influenza Surveillance Report","author":"New South Wales Government","year":"2020","unstructured":"New South Wales Government. Influenza Surveillance Report. 2020."},{"key":"11765_CR31","volume-title":"Public Health Science data platform","author":"Chinese Center for Disease Control and Prevention","year":"2020","unstructured":"Chinese Center for Disease Control and Prevention. Public Health Science data platform. 2020."},{"key":"11765_CR32","unstructured":"Chinese National Influenza Center. Influenza weekly report. Chinese National Influenza Center website 2020."},{"key":"11765_CR33","volume-title":"Gazette of National Health Commission","author":"National Health Commission","year":"2019","unstructured":"National Health Commission. Gazette of National Health Commission. 2019."},{"key":"11765_CR34","volume-title":"Malaysia influenza surveillance protocol","author":"S Sengol","year":"2018","unstructured":"Sengol S, Norizah I, Yusof M, Thayan R. Malaysia influenza surveillance protocol; 2018."},{"key":"11765_CR35","volume-title":"Asia-Pacific Alliance for the Control of Influenza","author":"APACI","year":"2020","unstructured":"APACI. Asia-Pacific Alliance for the Control of Influenza. 2020."},{"key":"11765_CR36","unstructured":"Australian FluTracking Team. FluTracking. https:\/\/info.flutracking.net\/. Accesssed 23 Sept 2021."},{"key":"11765_CR37","unstructured":"GIHSN - Global Influenza Hospital Surveillance Network. https:\/\/www.gihsn.org\/. Accessed 1 Jun 2020."},{"key":"11765_CR38","unstructured":"China National Bureau of Statistics. China Statistical Yearbook. 2020."},{"key":"11765_CR39","unstructured":"GISAID. GISAID - Mission. https:\/\/www.gisaid.org\/about-us\/mission\/. Accessed 23 Sept 2021."},{"issue":"9","key":"11765_CR40","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1016\/S2468-2667(19)30163-X","volume":"4","author":"L Li","year":"2019","unstructured":"Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, et al. Influenza-associated excess respiratory mortality in China, 2010\u201315: a population-based study. Lancet Public Health. 2019;4(9):e473\u201381. https:\/\/doi.org\/10.1016\/S2468-2667(19)30163-X.","journal-title":"Lancet Public Health"},{"issue":"1","key":"11765_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12879-015-0884-1","volume":"15","author":"Z Peng","year":"2015","unstructured":"Peng Z, Feng L, Carolyn GM, Wang K, Zhu G, Zhang Y, et al. Characterizing the epidemiology, virology, and clinical features of influenza in China\u2019s first severe acute respiratory infection sentinel surveillance system, February 2011 \u2013 October 2013. BMC Infect Dis. 2015;15(1):143. https:\/\/doi.org\/10.1186\/s12879-015-0884-1.","journal-title":"BMC Infect Dis"},{"key":"11765_CR42","unstructured":"EUROMOMO. https:\/\/www.euromomo.eu\/. Accessed 1 Jun 2020."},{"key":"11765_CR43","unstructured":"US Center for Disease Control and Prevention (CDC). Disease Burden of Influenza. 2020. https:\/\/www.cdc.gov\/flu\/about\/burden\/index.html.\u00a0 Accessed 23 Sept 2021."},{"key":"11765_CR44","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1097\/01.ede.0000392141.28009.8d","volume":"22","author":"C-Q Ou","year":"2011","unstructured":"Ou C-Q, He J-F, Deng A-P, Yang L, Chan K-P, Chen P-Y, et al. Influenza surveillance and excess associated mortality in Guangzhou, China. Epidemiology. 2011;22:S153. https:\/\/doi.org\/10.1097\/01.ede.0000392141.28009.8d.","journal-title":"Epidemiology"},{"issue":"1","key":"11765_CR45","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12879-017-2863-1","volume":"17","author":"X Yu","year":"2017","unstructured":"Yu X, Wang C, Chen T, Zhang W, Yu H, Shu Y, et al. Excess pneumonia and influenza mortality attributable to seasonal influenza in subtropical Shanghai, China. BMC Infect Dis. 2017;17(1):756. https:\/\/doi.org\/10.1186\/s12879-017-2863-1.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"11765_CR46","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1080\/21645515.2019.1693721","volume":"16","author":"L Qi","year":"2020","unstructured":"Qi L, Li Q, Ding X-B, Gao Y, Ling H, Liu T, et al. Mortality burden from seasonal influenza in Chongqing, China, 2012\u20132018. Hum Vaccin Immunother. 2020;16(7):1668\u201374. https:\/\/doi.org\/10.1080\/21645515.2019.1693721.","journal-title":"Hum Vaccin Immunother"},{"key":"11765_CR47","unstructured":"Malaysia Ministry of Health. Immunise4life. 2020. https:\/\/www.immunise4life.my\/about-us\/. Accessed 23 Sept 2021."},{"issue":"27","key":"11765_CR48","doi-asserted-by":"publisher","first-page":"1900708","DOI":"10.2807\/1560-7917.ES.2020.25.27.1900708","volume":"25","author":"J Beaut\u00e9","year":"2020","unstructured":"Beaut\u00e9 J, Ciancio BC, Panagiotopoulos T. Infectious disease surveillance system descriptors: proposal for a comprehensive set. Eurosurveillance. 2020;25(27):1900708. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.27.1900708.","journal-title":"Eurosurveillance."},{"key":"11765_CR49","volume-title":"Influenza Surveillance Country, Territory and Area Profiles 2019","author":"European Centre for Disease Prevention and Control","year":"2019","unstructured":"European Centre for Disease Prevention and Control. Influenza Surveillance Country, Territory and Area Profiles 2019. 2019. http:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/publications\/2017\/influenza-surveilance-country,-teritory-and-area-profiles-2017t."},{"issue":"6","key":"11765_CR50","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/cid\/cix461","volume":"65","author":"AHL Bruning","year":"2017","unstructured":"Bruning AHL, Leeflang MMG, Vos JMBW, Spijker R, de Jong MD, Wolthers KC, et al. Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and Meta-analysis. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2017;65(6):1026\u201332. https:\/\/doi.org\/10.1093\/cid\/cix461.","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"issue":"10","key":"11765_CR51","doi-asserted-by":"publisher","first-page":"e002925","DOI":"10.1136\/bmjgh-2020-002925","volume":"5","author":"P Jia","year":"2020","unstructured":"Jia P, Yang S. Early warning of epidemics: towards a national intelligent syndromic surveillance system (NISSS) in China. BMJ Glob Health. 2020;5(10):e002925. https:\/\/doi.org\/10.1136\/bmjgh-2020-002925.","journal-title":"BMJ Glob Health"},{"key":"11765_CR52","unstructured":"World Health Organization. Pandemic Influenza Preparedness. https:\/\/www.who.int\/influenza\/pip\/en\/. Accessed 7 Jan 2020."},{"key":"11765_CR53","volume-title":"2019\u20132020 influenza season: repurposing surveillance systems for COVID-19","author":"World Health Organization Europe","year":"2020","unstructured":"World Health Organization Europe. 2019\u20132020 influenza season: repurposing surveillance systems for COVID-19. 2020. https:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/news\/news\/2020\/5\/20192020-influenza-season-repurposing-surveillance-systems-for-covid-19. Accessed 30 Sep 2020."},{"key":"11765_CR54","volume-title":"Operational considerations for COVID-19 surveillance using GISRS: interim guidance","author":"Global Influenza Programme WEP","year":"2020","unstructured":"Global Influenza Programme WEP. Operational considerations for COVID-19 surveillance using GISRS: interim guidance. 2020."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11765-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11765-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11765-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:03:29Z","timestamp":1632614609000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11765-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11765"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11765-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Approval by ethics committees and patient consent were not required because no individual data and only aggregated information were collected from literature search or publicly available websites.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CEG, JKY, AW are employees of Sanofi Pasteur which is developing influenza vaccines.TRdeF and OV reported consultancy fees paid to Corporate Value Associates by Sanofi Pasteur, during the conduct of the study; and outside of the submitted work.KS, receives a salary from the APACI which has received funding towards some of its activities from industry sources, including Roche and Seqirus, outside of the submitted work.LJ, is a director of the APACI.ZS, received grants from Research Grant on influenza project, from null, outside the submitted work.PV received grants from ANIOS, MSD and Sanofi, consulting fees from GSK and PFIZER ASTELLAS, outside of the submitted work.PVB, YS, LYS, TW and FS have no conflict of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1750"}}